BTSG Ahead of Q3 Earnings: Can Growth Offset Ongoing IRA Risks?

BrightSpring Health Services, Inc. BTSG is scheduled to report third-quarter 2026 results on Oct. 30, before market hours.

Zacks Investment Research • 7 hours ago

BTSG Stock Climbs 67.3% YTD: What's Driving the Rally in 2026?

BrightSpring's shares surge 67.3% year to date, fueled by strong pharmacy and provider growth, improving profitability and a brighter 2026 outlook.

Zacks Investment Research • Oct 14, 2026

BrightSpring: Margins Keep Improving While Expanding Its Pharmacy Footprint

I believe BrightSpring Health Services' pharmacy and home-care businesses have a few ways to monetize their sizeable revenues into higher EBITDA over time. BTSG's new oncology distribution wins also grow their addressable market, which is why drug adoption is vital going forward. BTSG's recently acquired home-health branches also have interesting potential as their integration progresses.

Seeking Alpha • Oct 14, 2026

Top Healthcare Stocks: Playing Offense And Defense For The Win

Healthcare offers investors a potential combination of offense with forward earnings and defense with rising demand amid persistent macro-economic uncertainty. The healthcare sector is positioned for above-average long-term growth, supported by aging demographics, rising medical demand, and increased spending that's expected to outpace the broader economy. Strong forward revenue, EBITDA, and earnings growth demonstrate how select healthcare services and facilities companies can significantly outperform their sector peers.

Seeking Alpha • Oct 12, 2026

BrightSpring Health Services, Inc. to Announce Third Quarter 2026 Financial Results on October 30, 2026

LOUISVILLE, Ky., Oct. 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2026 financial results on Friday, October 30, 2026, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day.

GlobeNewsWire • Oct 1, 2026

BrightSpring Health Services, Inc. (BTSG) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Sep 30, 2026

BTSG Deploys AI Across Operations: Will It Improve Margins?

BrightSpring Health Services is expanding AI and automation across its operations, with early margin gains and more benefits expected later in 2026 and 2027.

Zacks Investment Research • Sep 30, 2026

BrightSpring vs. Option Care Health: Which Healthcare Stock Is Better?

BrightSpring's faster growth, pharmacy and provider-service expansion, and improving margins contrast with OPCH's slower growth and chronic-therapy pressures.

Zacks Investment Research • Sep 29, 2026

BrightSpring Health Targets Growth Through Specialty Pharmacy, M&A and AI

BrightSpring Health Services NASDAQ: BTSG outlined its growth strategy across pharmacy and provider services at the Bernstein healthcare services conference, emphasizing specialty pharmacy expansion, home health acquisitions, technology investments and opportunities to integrate services for complex patients.

MarketBeat • Sep 27, 2026

Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve?

BTSG's stronger cash flow and lower leverage could give it more flexibility to pursue acquisitions and support future growth.

Zacks Investment Research • Sep 25, 2026